We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MBIO market cap is 10.51M. The company's latest EPS is USD -3.5981 and P/E is -0.66.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 964k |
| Operating Income | -5.23M | -5.89M | -1.46M | 26k | -253k |
| Net Income | -5.19M | -8.2M | -1.41M | -952k | -153k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -56.81M | -66.72M | -76.16M | -50.73M | -12.55M |
| Net Income | -60.02M | -66.37M | -77.53M | -51.6M | -15.75M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.59M | 8.52M | 7.19M | 9.31M | 14.91M |
| Total Liabilities | 19.54M | 16.85M | 15.85M | 13.18M | 11.3M |
| Total Equity | -4.94M | -8.33M | -8.66M | -3.87M | 3.61M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 109.9M | 125.17M | 92.42M | 17.74M | 9.31M |
| Total Liabilities | 11.47M | 12.77M | 46.15M | 17.62M | 13.18M |
| Total Equity | 98.44M | 112.4M | 46.27M | 123k | -3.87M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.32M | -7.66M | -9.41M | -11.41M | -1.39M |
| Investing | N/A | N/A | N/A | N/A | 1.17M |
| Financing | 49k | 5.32M | 6.33M | 11.27M | 7.62M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -37.32M | -53.67M | -65.07M | -49.48M | -11.41M |
| Investing | -4.41M | -5.37M | -2.95M | 5.89M | N/A |
| Financing | 78.12M | 70.85M | 34.06M | -26.08M | 11.27M |
| Market Cap | 10.51M |
| Price to Earnings Ratio | -0.66 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.52 |
| Price to Book Ratio | -2.68 |
| Dividend Yield | - |
| Shares Outstanding | 4.38M |
| Average Volume (1 week) | 8.07M |
| Average Volume (1 Month) | 19.57M |
| 52 Week Change | -88.04% |
| 52 Week High | 24.00 |
| 52 Week Low | 0.8926 |
| Spread (Intraday) | 0.06 (2.44%) |
| Company Name | Mustang Bio Inc |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.mustangbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
